A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.
Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.
Tufts Clinical and Translational Science Institute (CTSI) has received a $78.4 million Clinical and Translational Science Award from the NIH, the fourth consecutive grant since its founding in 2008.
Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
Researchers from the Division of Endocrinology at Tufts Medical Center found that vitamin D was effective in lowering the risk for developing diabetes in adults with prediabetes.
MIRI PI Patrick Catalano, MD, has been awarded an R21 from the NIH/NICHD as Multi-Site PI for a two-year study entitled, “Impact of a Postpartum Lifestyle Intervention on Lactation Outcomes, Breastmilk Composition and Infant Growth.”
For years, glioblastoma, an aggressive form of brain cancer, has frustrated scientists and researchers. But while there is no known cure for this deadly disease, new, cutting-edge research may provide a life-prolonging option for glioblastoma patients and their families.
Internationally esteemed "think and do" tank moved to the new Center for Biomedical System Design within Tufts MC's Institute for Clinical Research and Health Policy Studies on July 5.
MIRI PI Dr. Michael House and his team members received a COVID-19 Rapid Response SeeD Funding Grant. This new funding program is intended to fast track innovative research proposals that directly address the urgent needs of the COVID-19 pandemic.
A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.